Naratriptan
- Generic Name
- Naratriptan
- Drug Type
- Small Molecule
- Chemical Formula
- C17H25N3O2S
- CAS Number
- 121679-13-8
- Unique Ingredient Identifier
- QX3KXL1ZA2
Overview
Naratriptan is a triptan drug that is selective for the 5-hydroxytryptamine1 receptor subtype. It is typically used for the treatment of migraine headaches.
Background
Naratriptan is a triptan drug that is selective for the 5-hydroxytryptamine1 receptor subtype. It is typically used for the treatment of migraine headaches.
Indication
For the acute treatment of migraine attacks with or without aura in adults.
Associated Conditions
- Migraine with acute onset aura
- Acute Migraine without aura
Clinical Trials
FDA Approved Products
Naratriptan
Manufacturer:Hikma Pharmaceuticals USA Inc.
Route:ORAL
Strength:2.5 mg in 1 1
Approved: 2020/04/01
NDC:0054-0279
Naratriptan
Manufacturer:Hikma Pharmaceuticals USA Inc.
Route:ORAL
Strength:1 mg in 1 1
Approved: 2020/04/01
NDC:0054-0278
Naratriptan
Manufacturer:Bionpharma Inc.
Route:ORAL
Strength:2.5 mg in 1 1
Approved: 2023/12/19
NDC:69452-341
Naratriptan
Manufacturer:OrchidPharma, Inc
Route:ORAL
Strength:1 mg in 1 1
Approved: 2022/01/13
NDC:42043-130
naratriptan
Manufacturer:Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
Route:ORAL
Strength:2.5 mg in 1 1
Approved: 2021/05/26
NDC:23155-055
Singapore Approved Products
NARATRIPTAN FILM-COATED TABLETS 2.5MG
Manufacturer:Chanelle Medical Unlimited Company
Form:TABLET, FILM COATED
Strength:2.50mg
Online:Yes
Approved: 2015/05/22
Approval:SIN14787P
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath